Search results for "Flora"

showing 10 items of 989 documents

Melatonin in Early Nutrition: Long-Term Effects on Cardiovascular System

2021

Breastfeeding protects against adverse cardiovascular outcomes in the long term. Melatonin is an active molecule that is present in the breast milk produced at night beginning in the first stages of lactation. This indoleamine appears to be a relevant contributor to the benefits of breast milk because it can affect infant health in several ways. The melatonin concentration in breast milk varies in a circadian pattern, making breast milk a chrononutrient. The consumption of melatonin can induce the first circadian stimulation in the infant’s body at an age when his/her own circadian machinery is not functioning yet. This molecule is also a powerful antioxidant with the ability to act on infa…

0301 basic medicineantioxidantcardiovascular disordersBreastfeedingPhysiologymelatoninStimulationReviewGut floraCardiovascular System0302 clinical medicinenewbornLactationNutritional Physiological PhenomenaBiology (General)Infant Nutritional Physiological PhenomenaSpectroscopybiologycardiovascular programmingfood and beveragesGeneral MedicineCircadian RhythmComputer Science ApplicationsChemistryBreast Feedingmedicine.anatomical_structureearly life nutritionbreast milkDisease Susceptibilitymedicine.symptomMetabolic Networks and Pathwaysmedicine.drugQH301-705.5InflammationBreast milkCatalysisInorganic ChemistryMelatonin03 medical and health sciencesmedicineAnimalsHumansLactationCircadian rhythmPhysical and Theoretical ChemistryQD1-999Molecular Biologygut microbiotabusiness.industryOrganic ChemistryInfant Newbornbiology.organism_classificationGastrointestinal MicrobiomeOxidative Stress030104 developmental biologycircadian rhythmsbusiness030217 neurology & neurosurgeryInternational Journal of Molecular Sciences
researchProduct

Microbiota Gut–Brain Axis in Ischemic Stroke: A Narrative Review with a Focus about the Relationship with Inflammatory Bowel Disease

2021

The gut microbiota is emerging as an important player in neurodevelopment and aging as well as in brain diseases including stroke, Alzheimer’s disease, and Parkinson’s disease. The complex interplay between gut microbiota and the brain, and vice versa, has recently become not only the focus of neuroscience, but also the starting point for research regarding many diseases such as inflammatory bowel diseases (IBD). The bi-directional interaction between gut microbiota and the brain is not completely understood. The aim of this review is to sum up the evidencesconcerningthe role of the gut–brain microbiota axis in ischemic stroke and to highlight the more recent evidences about the potential r…

0301 basic medicinebrainScienceGut–brain axisReviewDiseaseGut floraBioinformaticsInflammatory bowel diseasedigestive systemGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciences0302 clinical medicineinflammatory bowel diseasemicrobiotaMedicineStrokeEcology Evolution Behavior and Systematicsbiologybusiness.industrystroke.digestive oral and skin physiologyQPaleontologyInflammatory Bowel Diseasesbiology.organism_classificationmedicine.diseasestrokestomatognathic diseases030104 developmental biologySpace and Planetary ScienceIschemic strokegutNarrative reviewbusiness030217 neurology & neurosurgeryLife
researchProduct

The Interplay between Nutrition, Innate Immunity, and the Commensal Microbiota in Adaptive Intestinal Morphogenesis

2021

The gastrointestinal tract is a functionally and anatomically segmented organ that is colonized by microbial communities from birth. While the genetics of mouse gut development is increasingly understood, how nutritional factors and the commensal gut microbiota act in concert to shape tissue organization and morphology of this rapidly renewing organ remains enigmatic. Here, we provide an overview of embryonic mouse gut development, with a focus on the intestinal vasculature and the enteric nervous system. We review how nutrition and the gut microbiota affect the adaptation of cellular and morphologic properties of the intestine, and how these processes are interconnected with innate immunit…

0301 basic medicineendotheliumimmunometabolismNutritional StatusReviewGut floraDiet High-Fatdigestive systemEnteric Nervous System03 medical and health sciencesMice0302 clinical medicinevascularizationmorphologymicrobiotaMorphogenesisAnimalsHomeostasisHumansTX341-641Intestinal MucosaSymbiosisintestinedevelopmentOrganismGastrointestinal tractNutrition and DieteticsInnate immune systembiologyNutrition. Foods and food supplyEpithelial Cellsbiology.organism_classificationEmbryonic stem cellImmunity InnateCell biologyGastrointestinal MicrobiomeGastrointestinal Tract030104 developmental biologynutritionhigh-fat diet030220 oncology & carcinogenesisEnteric nervous systemAdaptationFood ScienceIntestinal morphogenesisNutrients
researchProduct

Ketogenic diet and microbiota: Friends or enemies?

2019

Over the last years, a growing body of evidence suggests that gut microbial communities play a fundamental role in many aspects of human health and diseases. The gut microbiota is a very dynamic entity influenced by environment and nutritional behaviors. Considering the influence of such a microbial community on human health and its multiple mechanisms of action as the production of bioactive compounds, pathogens protection, energy homeostasis, nutrients metabolism and regulation of immunity, establishing the influences of different nutritional approach is of pivotal importance. The very low carbohydrate ketogenic diet is a very popular dietary approach used for different aims: from weight …

0301 basic medicinelcsh:QH426-470medicine.medical_treatmentReviewGut microbiotaBiologyGut floraBioinformaticsEnergy homeostasis03 medical and health sciencesHuman health0302 clinical medicineWeight lossGeneticsmedicineAnimalsHumansLow carbohydrateGenetics (clinical)Gut microbiomeBiological Variation IndividualMicrobiotaKetogenic diet and fatKetosisKetogenic dietbiology.organism_classificationGut microbiomeIntestinal microbiomeGastrointestinal Microbiomelcsh:Genetics030104 developmental biologyIntestinal MicrobiomeCarbohydrate Metabolismgut microbiome; gut microbiota; intestinal microbiome; ketogenic diet; ketogenic diet and fatmedicine.symptomDiet Ketogenic030217 neurology & neurosurgeryKetogenic diet
researchProduct

The Monoclonal Antitoxin Antibodies (Actoxumab–Bezlotoxumab) Treatment Facilitates Normalization of the Gut Microbiota of Mice with Clostridium diffi…

2016

Antibiotics have significant and long-lasting impacts on the intestinal microbiota and consequently reduce colonization resistance against Clostridium difficile infection (CDI). Standard therapy using antibiotics is associated with a high rate of disease recurrence, highlighting the need for novel treatment strategies that target toxins, the major virulence factors, rather than the organism itself. Human monoclonal antibodies MK-3415A (actoxumab–bezlotoxumab) to C. difficile toxin A and toxin B, as an emerging non-antibiotic approach, significantly reduced the recurrence of CDI in animal models and human clinical trials. Although the main mechanism of protection is through direct neutraliza…

0301 basic medicinelcsh:QR1-502gut microbiomeGut floralcsh:MicrobiologyantibioticsMiceLactobacillusLongitudinal StudiesOriginal Researchbiologyactoxumab and bezlotoxumabMK-3415AAntibodies MonoclonalClostridium difficile3. Good healthAnti-Bacterial AgentsInfectious DiseasesTreatment Outcome16S rDNA amplicon sequencingVancomycinmedicine.drugMicrobiology (medical)030106 microbiologyImmunologyClostridium difficile toxin AColonisation resistanceC. difficile toxin antibodyMicrobiologyMicrobiology03 medical and health sciencesVancomycinClostridium difficile infectionimmune therapymedicineAnimalsClostridioides difficileAkkermansiabiology.organism_classificationAntibodies NeutralizingSurvival AnalysisGastrointestinal MicrobiomeDisease Models Animal030104 developmental biologyBayesian networksBezlotoxumabImmunologyClostridium InfectionsAntitoxinsBroadly Neutralizing AntibodiesFrontiers in Cellular and Infection Microbiology
researchProduct

2019

The gut microbiota influence host vascular physiology locally in the intestine, but also evoke remote effects that impact distant organ functions. Amongst others, the microbiota affect intestinal vascular remodeling, lymphatic development, cardiac output and vascular function, myelopoiesis, prothrombotic platelet function, and immunovigilance of the host. Experimentally, host-microbiota interactions are investigated by working with animals devoid of symbiotic bacteria, i.e., by the decimation of gut commensals by antibiotic administration, or by taking advantage of germ-free mouse isolator technology. Remarkably, some of the vascular effects that were unraveled following antibiotic treatmen…

0301 basic medicinemedicine.drug_classImmunologyAntibioticsBiologyGut floraCommensalismbiology.organism_classification03 medical and health sciences030104 developmental biology0302 clinical medicineLymphatic systemImmunologymedicineImmunology and AllergyPlateletMyelopoiesisFunction (biology)030215 immunologySymbiotic bacteriaFrontiers in Immunology
researchProduct

<p>The microbiota of the bilio-pancreatic system: a cohort, STROBE-compliant study</p>

2019

Background: The gut microbiota play an essential role in protecting the host against pathogenic microorganisms by modulating immunity and regulating metabolic processes. In response to environmental factors, microbes can hugely alter their metabolism. These factors can substantially impact the host and have potential pathologic implications. Particularly pathogenic microorganisms colonizing pancreas and biliary tract tissues may be involved in chronic inflammation and cancer evolution. Purpose: To evaluate the effect of bile microbiota on survival in patients with pancreas and biliary tract disease (PBD). Patients and Methods: We investigated 152 Italian patients with cholelithiasis (CHL), …

0301 basic medicinemedicine.medical_specialty030106 microbiologyGut floraGastroenterology03 medical and health sciences0302 clinical medicineImmunityInternal medicineCarcinomaMedicinePharmacology (medical)030212 general & internal medicinePharmacologybiologybusiness.industryGallbladderCancermedicine.diseasebiology.organism_classificationInfectious Diseasesmedicine.anatomical_structureBiliary tractPancreatitisbusinessPancreasInfection and Drug Resistance
researchProduct

Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imb…

2016

Gut microbiota is involved in obesity, metabolic syndrome and the progression of nonalcoholic fatty liver disease (NAFLD). It has been recently suggested that the flavonoid quercetin may have the ability to modulate the intestinal microbiota composition, suggesting a prebiotic capacity which highlights a great therapeutic potential in NAFLD. The present study aims to investigate benefits of experimental treatment with quercetin on gut microbial balance and related gut-liver axis activation in a nutritional animal model of NAFLD associated to obesity. C57BL/6J mice were challenged with high fat diet (HFD) supplemented or not with quercetin for 16 weeks. HFD induced obesity, metabolic syndrom…

0301 basic medicinemedicine.medical_specialtyGut floraDiet High-FatBiochemistryMice03 medical and health sciencesNon-alcoholic Fatty Liver DiseasePhysiology (medical)Internal medicineNonalcoholic fatty liver diseasemedicineAnimalsHumansObesityMetabolic SyndromebiologyFatty liverLipid metabolismLipid Metabolismmedicine.diseasebiology.organism_classificationGastrointestinal MicrobiomeIntestinesToll-Like Receptor 4Disease Models Animal030104 developmental biologyEndocrinologyLiverLipotoxicityImmunologyQuercetinInsulin ResistanceSteatosisMetabolic syndromeDysbiosisSignal TransductionFree Radical Biology and Medicine
researchProduct

AB0492 INTESTINAL MICROBIOTA COMPOSITION OF PATIENT’S WITH BEHCET’S DISEASE: DIFFERENCES BETWEEN EYE, MUCOCUTANEOUS AND VASCULAR INVOLVEMENT (RHEUMA-…

2020

Background:Recently, it has been shown that changes in microbiota composition play a role in the etiology and pathogenesis of chronic diseases. Changes in oral and intestinal microbiota diversity and composition are suggested in Behcet disease (BD), however there are no study available about the potential gut microbiota changes among different clinical forms of BD.Objectives:The aim of this study was to evaluate the intestinal microbiota composition of patient with BD and healthy controls, and also compare BD patients regarding to their eye, mucocutaneous and vascular involvement.Methods:In this prospective cohort study,27 patients diagnosed with BD and 10 aged and sex matched healthy contr…

0301 basic medicinemedicine.medical_specialtyImmunologyMucocutaneous zoneEggerthella lentaBehcet's diseaseGut floraSutterellaGastroenterologyGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciences0302 clinical medicineRheumatologyInternal medicinemedicineImmunology and Allergy030203 arthritis & rheumatologybiologybusiness.industryAkkermansiabiology.organism_classificationmedicine.disease030104 developmental biologybusinessActinomycesEggerthellaAnnals of the Rheumatic Diseases
researchProduct

Intestinal microbiota mediates the beneficial effects of n-3 polyunsaturated fatty acids during dietary obesity,

2021

Obesity, now considered as a real worldwide epidemic affecting more than 650 million people, is complex and mainly associated with excessive energy intake and changes in eating habits favoring the consumption of diets rich in saturated fat and sugar. This multifactorial pathology is linked to chronic low grade systemic inflammation. Indeed, a high fat diet (HFD) leads to intestinal microbiota dysbiosis increasing gut permeability (partly attributed to a downregulation of genes encoding tight junction proteins) leading to an increase in bacterial lipopolysaccharides (LPS) levels so-called metabolic endotoxemia. Studies have shown that n-3 polyunsaturated fatty acids (PUFAs) are involved in t…

0301 basic medicinemedicine.medical_specialtydietary obesitySaturated fatlcsh:TP670-699fat-1 miceBiologyGut floraBiochemistry03 medical and health sciences0302 clinical medicineInsulin resistanceInternal medicinemicrobiotamedicinefecal transplantationchemistry.chemical_classificationIntestinal permeabilitymetabolic endotoxemiamedicine.diseasebiology.organism_classificationObesityn-3 polyunsaturated fatty acids030104 developmental biologyEndocrinologychemistry030220 oncology & carcinogenesislcsh:Oils fats and waxesMetabolic syndromeAgronomy and Crop ScienceDysbiosisFood SciencePolyunsaturated fatty acidOCL
researchProduct